Clinical trials
Hepatitis C trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 1 |
| 2017 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Enrolling by invitation | 1 |
| No longer available | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Gilead Sciences | 3 |
| Charles University, Czech Republic | 2 |
| GlaxoSmithKline | 2 |
| Human Genome Sciences Inc. | 2 |
| AbbVie | 1 |
| Astellas Pharma Inc | 1 |
| Institute of Health Information and Statistics of the Czech Republic | 1 |
| Janssen Infectious Diseases BVBA | 1 |
| Janssen R&D Ireland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 20 |
| Hepatitis C, Chronic | 8 |
| Hepatitis | 2 |
| Acidosis, Lactic | 1 |
| Acquired Immunodeficiency Syndrome | 1 |
| Cardiovascular Diseases | 1 |
| Coinfection | 1 |
| Diabetes Mellitus | 1 |
| End Stage Liver Disease | 1 |
| Fibrosis | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.